PURPOSE: In this work, we compare susceptometry-based oximetry (SBO) and two T2 -based methods for estimating resting baseline SvO2 in the superior sagittal sinus (SSS). METHODS: SBO is a field-mapping technique whereas in T2 -based methods the intravascular blood signal is isolated either with velocity-encoded projections [projection-based T2 (PT2 )] or a tag-control scheme [T2 -relaxation under spin tagging (TRUST)] after T2 -preparation. The measurements were performed on twelve healthy subjects (mean age = 33 ± 6 years) at 3 Tesla field strength. The reliability, precision, and reproducibility were examined for the three techniques. RESULTS: The mean (± standard deviation) SvO2 quantified by SBO, PT2 , and TRUST were found to be 65.9 ± 3.3, 65.6 ± 3.5, and 63.2 ± 4.1%. The standard deviation (SD) for 10 consecutive measurements in the quantified SvO2 was less than 2.7%, 4.7%, and 5.0% for SBO, PT2 , and TRUST across all subjects. In testing reproducibility across different days, the resulting SDs were 2.6, 3.5, and 2.0% for SBO, PT2 , and TRUST. CONCLUSION: The results indicate that all three SvO2 quantification techniques to be reliable with good agreement between PT2 and SBO while TRUST yielded slightly lower values compared with the other two techniques.
PURPOSE: In this work, we compare susceptometry-based oximetry (SBO) and two T2 -based methods for estimating resting baseline SvO2 in the superior sagittal sinus (SSS). METHODS:SBO is a field-mapping technique whereas in T2 -based methods the intravascular blood signal is isolated either with velocity-encoded projections [projection-based T2 (PT2 )] or a tag-control scheme [T2 -relaxation under spin tagging (TRUST)] after T2 -preparation. The measurements were performed on twelve healthy subjects (mean age = 33 ± 6 years) at 3 Tesla field strength. The reliability, precision, and reproducibility were examined for the three techniques. RESULTS: The mean (± standard deviation) SvO2 quantified by SBO, PT2 , and TRUST were found to be 65.9 ± 3.3, 65.6 ± 3.5, and 63.2 ± 4.1%. The standard deviation (SD) for 10 consecutive measurements in the quantified SvO2 was less than 2.7%, 4.7%, and 5.0% for SBO, PT2 , and TRUST across all subjects. In testing reproducibility across different days, the resulting SDs were 2.6, 3.5, and 2.0% for SBO, PT2 , and TRUST. CONCLUSION: The results indicate that all three SvO2 quantification techniques to be reliable with good agreement between PT2 and SBO while TRUST yielded slightly lower values compared with the other two techniques.
Authors: Varsha Jain; Michael C Langham; Thomas F Floyd; Gaurav Jain; Jeremy F Magland; Felix W Wehrli Journal: J Cereb Blood Flow Metab Date: 2011-04-20 Impact factor: 6.200
Authors: Zachary B Rodgers; Varsha Jain; Erin K Englund; Michael C Langham; Felix W Wehrli Journal: J Cereb Blood Flow Metab Date: 2013-07-10 Impact factor: 6.200
Authors: Cheng Li; Michael C Langham; Charles L Epstein; Jeremy F Magland; Jue Wu; James Gee; Felix W Wehrli Journal: Magn Reson Med Date: 2011-08-19 Impact factor: 4.668
Authors: Suliman Barhoum; Michael C Langham; Jeremy F Magland; Zachary B Rodgers; Cheng Li; Chamith S Rajapakse; Felix W Wehrli Journal: J Cereb Blood Flow Metab Date: 2015-05-13 Impact factor: 6.200
Authors: Zhiliang Wei; Jiadi Xu; Peiying Liu; Lin Chen; Wenbo Li; Peter van Zijl; Hanzhang Lu Journal: Magn Reson Med Date: 2017-12-21 Impact factor: 4.668
Authors: Zachary B Rodgers; Erin K Englund; Michael C Langham; Jeremy F Magland; Felix W Wehrli Journal: Neuroimage Date: 2014-11-04 Impact factor: 6.556
Authors: Antonio M Chiarelli; Michael Germuska; Hannah Chandler; Rachael Stickland; Eleonora Patitucci; Emma Biondetti; Daniele Mascali; Neeraj Saxena; Sharmila Khot; Jessica Steventon; Catherine Foster; Ana E Rodríguez-Soto; Erin Englund; Kevin Murphy; Valentina Tomassini; Felix W Wehrli; Richard G Wise Journal: J Cereb Blood Flow Metab Date: 2022-02-02 Impact factor: 6.960